Nonsentinel lymph nodes key factor in melanoma prognosis

Nonsentinel lymph nodes key factor in melanoma prognosis
Nonsentinel lymph node positivity is a significant prognostic factor in patients with stage III melanoma, associated with shorter overall and disease-specific survival, according to research published online July 31 in JAMA Surgery.

(HealthDay)—Nonsentinel lymph node (NSLN) positivity is a significant prognostic factor in patients with stage III melanoma, associated with shorter overall and disease-specific survival, according to research published online July 31 in JAMA Surgery.

Anna M. Leung, M.D., of St. John's Health Center in Santa Monica, Calif., and colleagues searched the database at the John Wayne Cancer Institute and identified patients with (SLNs) positive for cutaneous melanoma who subsequently underwent completion . The survival associated with disease limited to SLNs and disease spread into NSLNs was examined.

The researchers found that 329 of 4,223 patients who underwent SLN biopsy from 1986 to 2012 had a tumor-positive SLN. Of these, 250 patients (76.0 percent) had no additional positive nodes and 79 patients (24.0 percent) had a tumor-positive NSLN. The NSLN-positive group had shorter overall median survival (42.2 versus 178 months), lower rate of five-year overall survival (46.4 versus 72.3 percent), shorter median melanoma-specific survival (60 months versus not yet reached), and lower rate of five-year melanoma-specific survival (49.5 versus 77.8 percent) than the SLN-only positive group.

"We propose that, for the next iteration of the , the committee performs an analysis of the independent prognostic impact of NSLN status," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: JAMA Surgery

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Nonsentinel lymph nodes key factor in melanoma prognosis (2013, August 2) retrieved 19 March 2024 from https://medicalxpress.com/news/2013-08-nonsentinel-lymph-nodes-key-factor.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Tumor-Infiltrating lymphocyte grade IDs melanoma survival

 shares

Feedback to editors